Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatic hydrothorax

R M Strauss1, T D Boyer

  • 1Division of Digestive Diseases, Emory University School of Medicine, Atlanta, GA 30322, USA.

Seminars in Liver Disease
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Hepatic hydrothorax, a pleural effusion in cirrhosis patients, often causes respiratory issues. Transjugular intrahepatic portal systemic shunts are the most effective treatment for refractory cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies.

Alimentary pharmacology & therapeutics·2017
Same author

Petrified ears associated with pseudopseudohypoparathyroidism.

The British journal of dermatology·2007
Same author

A retrospective study addressed to understanding what predicts severe histological dysplasia/early melanoma in excised atypical melanocytic lesions.

The British journal of dermatology·2007
Same author

Is minocycline therapy in acne associated with antineutrophil cytoplasmic antibody positivity? A cross-sectional study.

The British journal of dermatology·2007
Same author

A child with laryngo-onychocutaneous syndrome partially responsive to treatment with thalidomide.

The British journal of dermatology·2006
Same author

Unilateral naevoid trichoepitheliomas on the face of a child.

Clinical and experimental dermatology·2006
Same journal

Endothelial Cell Therapy for the Acute and Chronic Liver Disease.

Seminars in liver disease·2026
Same journal

Neutrophils in Liver Diseases: Functions and Challenging Therapies.

Seminars in liver disease·2026
Same journal

Expert Practical Recommendations for Hepatocellular Carcinoma.

Seminars in liver disease·2026
Same journal

Optimizing Liver Cancer Care Through BCLC Principles.

Seminars in liver disease·2026
Same journal

Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates.

Seminars in liver disease·2026
Same journal

Practical Guide to Best Practices in Alcohol-Associated Liver Disease.

Seminars in liver disease·2026
See all related articles

Area of Science:

  • Hepatology
  • Pulmonology
  • Interventional Radiology

Background:

  • Ascites and pleural effusion are common in cirrhosis patients.
  • Hepatic hydrothorax occurs when ascites moves to the pleural space via diaphragmatic defects.
  • Significant respiratory symptoms can arise from small pleural effusions.

Purpose of the Study:

  • To summarize the understanding and treatment of hepatic hydrothorax in cirrhosis.
  • To highlight the effectiveness of transjugular intrahepatic portal systemic shunts.

Main Methods:

  • Review of existing studies on hepatic hydrothorax.
  • Analysis of treatment outcomes for refractory cases.

Main Results:

  • Hepatic hydrothorax is typically right-sided and linked to portal hypertension.

Related Experiment Videos

  • Medical management (salt restriction, diuretics) is the first line of treatment.
  • Transjugular intrahepatic portal systemic shunts show the most promise for refractory hepatic hydrothorax.

    • Conclusions:

    • Hepatic hydrothorax requires prompt management due to potential respiratory compromise.
    • Transjugular intrahepatic portal systemic shunts represent a leading treatment option for refractory hepatic hydrothorax.